Hot Features
Argenica Therapeutics Limited, a biotechnology company, engages in the research and development of neuroprotective therapeutic drugs in Australia. Its lead product candidate is ARG-007, a neuroprotective peptide candidate, which is in phase 2 clinical trial to reduce brain tissue death after stroke ... Argenica Therapeutics Limited, a biotechnology company, engages in the research and development of neuroprotective therapeutic drugs in Australia. Its lead product candidate is ARG-007, a neuroprotective peptide candidate, which is in phase 2 clinical trial to reduce brain tissue death after stroke and other types of brain injury. The company was incorporated in 2019 and is based in Nedlands, Australia. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.02 | 18.1818181818 | 0.11 | 0.13 | 0.11 | 183203 | 0.12194437 | DE |
| 4 | -0.04 | -23.5294117647 | 0.17 | 0.175 | 0.11 | 215744 | 0.13138777 | DE |
| 12 | -0.09 | -40.9090909091 | 0.22 | 0.23 | 0.11 | 147800 | 0.14710616 | DE |
| 26 | -0.11 | -45.8333333333 | 0.24 | 0.345 | 0.11 | 185276 | 0.22133503 | DE |
| 52 | -0.65 | -83.3333333333 | 0.78 | 0.79 | 0.11 | 267254 | 0.30635687 | DE |
| 156 | -0.27 | -67.5 | 0.4 | 0.985 | 0.11 | 181860 | 0.48899892 | DE |
| 260 | -0.14 | -51.8518518519 | 0.27 | 1.02 | 0.11 | 180138 | 0.45359356 | DE |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.